Tajinder Vohra Net Worth

The estimated Net Worth of Tajinder S Vohra is at least $3.57 Milion dollars as of 21 December 2022. Mr Vohra owns over 3,325 units of Revvity stock worth over $2,175,292 and over the last 16 years he sold PKI stock worth over $0. In addition, he makes $1,397,645 as Sr. VP of Global Operations at Revvity.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Vohra PKI stock SEC Form 4 insiders trading

Mr has made over 2 trades of the Revvity stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 3,325 units of PKI stock worth $162,859 on 21 December 2022.

The largest trade he's ever made was exercising 3,325 units of Revvity stock on 21 December 2022 worth over $162,859. On average, Mr trades about 166 units every 0 days since 2008. As of 21 December 2022 he still owns at least 18,868 units of Revvity stock.

You can see the complete history of Mr Vohra stock trades at the bottom of the page.

Mr. Tajinder Vohra biography

Tajinder Vohra is the Sr. VP of Global Operations at Revvity.

What is the salary of Mr Vohra?

As the Sr. VP of Global Operations of Revvity, the total compensation of Mr Vohra at Revvity is $1,397,645. There are 7 executives at Revvity getting paid more, with Dr. Prahlad R. Singh Ph.D. having the highest compensation of $4,862,149.

How old is Mr Vohra?

Mr Vohra is 55, he's been the Sr. VP of Global Operations of Revvity since . There are 8 older and 12 younger executives at Revvity. The oldest executive at Revvity Inc. is Peter Barrett, 67, who is the Independent Director.

What's Mr Vohra's mailing address?

Tajinder's mailing address filed with the SEC is 940, Winter Street, Prospectville, Waltham, Middlesex County, Massachusetts, 02451, United States.

Insiders trading at Revvity

Over the last 26 years, insiders at Revvity have traded over $204,298,889 worth of Revvity stock and bought 55,200 units worth $1,110,570 . The most active insiders traders include Alexis P Michas, Gregory L Summe a Robert F Friel. On average, Revvity executives and independent directors trade stock every 25 days with the average trade being worth of $6,184,617. The most recent stock trade was executed by Andrew Okun on 13 April 2023, trading 2,435 units of PKI stock currently worth $332,402.

What does Revvity do?

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.

Complete history of Mr Vohra stock trades at Genpact Ltd a Revvity

Revvity executives and stock owners

Revvity executives and other stock owners filed with the SEC include:

• Dr. Prahlad R. Singh Ph.D.,
  CEO, Pres & Director
• Prahlad Singh,
  President, Chief Executive Officer, Director
• Joel Goldberg,
  Senior Vice President - Administration, General Counsel, Secretary
• James M. Mock,
  Sr. VP & CFO
• Joel S. Goldberg,
  Sr. VP of Admin., Gen. Counsel & Sec.
• James Mock,
  Chief Financial Officer, Senior Vice President
• Deborah Butters,
  Chief Human Resource Officer, Senior Vice President
• Tajinder Vohra,
  Sr. VP of Global Operations
• Alexandros Michas,
  Independent Non-Executive Chairman of the Board
• Samuel Chapin,
  Independent Director
• Peter Barrett,
  Independent Director
• Pascale Witz,
  Independent Director
• Frank Witney,
  Independent Director
• Sylvie Gregoire,
  Independent Director
• Michel Vounatsos,
  Independent Director
• Andrew Okun,
  Chief Accounting Officer, Vice President
• Tajinder Vohra,
  Senior Vice President, Global Operations
• Daniel Tereau,
  Senior Vice President, Strategy and Business Development
• Masoud Toloue,
  Sr. VP of Diagnostics
• Miriame Victor,
  Sr. VP & Chief Commercial Officer
• Robert Francis Friel,
  Advisor
• Stephen Barr Willoughby,
  VP of Investor Relations
• Andrew Okun,
  VP, Chief Accounting Officer & Treasurer
• Michelle Mc Murry Heath,
  Director
• Nicholas A Lopardo,
  Director
• James Corbett,
  See Remarks
• Alexis P Michas,
  Director
• Vicki L Sato,
  Director
• Kenton J Sicchitano,
  Director
• Robert F Friel,
  Chief Financial Officer
• Patrick J Sullivan,
  Director
• Frank Anders Wilson,
  SVP, CFO & CAO
• John A Roush,
  Vice President
• Michael Louis Battles,
  VP & Chief Accounting Officer
• Jeffrey D Capello,
  Chief Accounting Officer
• Gregory L Summe,
  Chairman & CEO
• Katherine A O Hara,
  SVP & General Counsel
• Richard F Walsh,
  Senior Vice President
• Tamara J Erickson,
  Director
• Robert A Barrett,
  Sr. Vice President
• Terrance L Carlson,
  Sr. VP & General Counsel
• Peter B Coggins,
  Sr. Vice President
• John Patrick Murphy,
  Sr. Vice President
• John R Letcher,
  Senior Vice President, HR
• Jonathan P. Di Vincenzo,
  See Remarks
• James C Mullen,
  Director
• Maurice H. Tenney,
  See Remarks
• Daniel R Marshak,
  SVP & CSO
• E Kevin Hrusovsky,
  See Remarks
• G Robert Tod,
  Director
• Gabriel Schmergel,
  Director
• Miriame Victor,
  Please See Remarks
• Maxwell Krakowiak,
  Please See Remarks